SONOMA PHARMACEUTICALS, INC. Net Income (Loss) Available to Common Stockholders, Basic
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Net Income (Loss) Available to Common Stockholders, Basic of -$1.02 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2022-11-14
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-09-30 was -$1.02M.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2022-06-30 was -$887.00K.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-12-31 was -$944.00K.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2021-09-30 was -$100.00K.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$8.20M, a 319.63% decline from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was $3.73M.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2013 was -$6.49M.
- SONOMA PHARMACEUTICALS, INC. net income (loss) available to common stockholders, basic for fiscal 2012 was -$7.33M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$1.02M 10-Q · filed 2022-11-14 | -$1.90M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$887.00K 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | -$944.00K 10-Q · filed 2022-02-11 | -$1.04M derived: sum of 2 quarters · filed 2022-11-14 | -$2.14M 10-Q · filed 2022-02-11 | |
| 2021-09-30 | -$100.00K 10-Q · filed 2022-11-14 | -$1.20M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$1.10M 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | -$650.00K 10-Q · filed 2022-02-11 | -$290.00K 10-Q · filed 2022-02-11 | ||
| 2015-03-31 | -$8.20M 10-K · filed 2015-06-16 | |||
| 2014-03-31 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-16 | $6.85M derived: sum of 2 quarters · filed 2015-06-16 | $5.45M derived: sum of 3 quarters · filed 2015-06-16 | $3.73M 10-K · filed 2015-06-16 |
| 2013-12-31 | -$611.00K 10-Q · filed 2014-02-14 | -$2.01M derived: sum of 2 quarters · filed 2014-02-14 | -$3.72M 10-Q · filed 2014-02-14 | -$6.17M derived: sum of 4 quarters · filed 2014-06-30 |
| 2013-09-30 | -$1.40M 10-Q · filed 2013-11-19 | -$3.11M 10-Q · filed 2013-11-19 | -$5.56M derived: sum of 3 quarters · filed 2014-06-30 | -$7.47M derived: sum of 4 quarters · filed 2014-06-30 |
| 2013-06-30 | -$1.71M 10-Q · filed 2013-08-14 | -$4.16M derived: sum of 2 quarters · filed 2014-06-30 | -$6.07M derived: sum of 3 quarters · filed 2014-06-30 | -$7.59M derived: sum of 4 quarters · filed 2014-06-30 |
| 2013-03-31 | -$2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | -$4.36M derived: sum of 2 quarters · filed 2014-06-30 | -$5.88M derived: sum of 3 quarters · filed 2014-06-30 | -$6.49M 10-K · filed 2014-06-30 |
| 2012-12-31 | -$1.91M 10-Q · filed 2014-02-14 | -$3.43M derived: sum of 2 quarters · filed 2014-02-14 | -$4.05M 10-Q · filed 2014-02-14 | -$5.82M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-09-30 | -$1.52M 10-Q · filed 2013-11-19 | -$2.14M 10-Q · filed 2013-11-19 | -$3.90M derived: sum of 3 quarters · filed 2013-11-19 | -$6.45M derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-06-30 | -$617.00K 10-Q · filed 2013-08-14 | -$2.38M derived: sum of 2 quarters · filed 2013-08-14 | -$4.93M derived: sum of 3 quarters · filed 2013-08-14 | |
| 2012-03-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | -$4.32M derived: sum of 2 quarters · filed 2013-06-25 | -$7.33M 10-K · filed 2013-06-25 | |
| 2011-12-31 | -$2.55M 10-Q · filed 2013-02-13 | -$5.56M 10-Q · filed 2013-02-13 | ||
| 2011-06-30 | -$2.17M 10-Q/A · filed 2012-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |